US Stock MarketDetailed Quotes

Xeris Pharmaceuticals (XERS)

Watchlist
  • 6.250
  • +0.070+1.13%
Trading Jun 8 13:12 ET
1.08BMarket Cap85.62P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xeris Pharmaceuticals (XERS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
38.27%83.13M
43.72%291.85M
42.78%85.81M
37.06%74.38M
48.84%71.54M
47.94%60.12M
23.89%203.07M
35.39%60.1M
12.31%54.27M
26.46%48.07M
Operating revenue
38.27%83.13M
43.72%291.85M
42.78%85.81M
37.06%74.38M
48.84%71.54M
47.94%60.12M
23.89%203.07M
35.39%60.1M
12.31%54.27M
26.46%48.07M
Cost of revenue
21.15%10.57M
15.58%42.57M
15.50%10.95M
-19.11%11M
52.73%11.9M
46.17%8.73M
28.58%36.83M
25.20%9.48M
65.75%13.59M
3.11%7.79M
Gross profit
41.18%72.55M
49.95%249.28M
47.88%74.86M
55.83%63.38M
48.08%59.64M
48.24%51.39M
22.89%166.24M
37.48%50.62M
1.39%40.68M
32.25%40.28M
Operating expense
18.64%64.64M
12.26%224.38M
18.69%58.09M
5.76%56.65M
13.82%55.16M
11.39%54.48M
11.49%199.88M
4.89%48.94M
18.96%53.57M
4.37%48.46M
Selling and administrative expenses
20.73%53.14M
11.56%182.37M
18.34%47.5M
3.31%46.46M
11.00%44.39M
14.69%44.02M
11.90%163.48M
6.84%40.14M
20.60%44.97M
6.27%39.99M
Research and development costs
13.29%8.78M
21.93%31.17M
29.25%7.87M
27.09%7.48M
39.87%8.06M
-0.87%7.75M
14.41%25.56M
-4.54%6.09M
16.96%5.89M
-5.39%5.76M
Depreciation amortization depletion
0.00%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.04%2.71M
-0.04%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
-Depreciation and amortization
0.00%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.04%2.71M
-0.04%2.71M
0.00%10.84M
0.00%2.71M
0.00%2.71M
0.00%2.71M
Operating profit
356.18%7.92M
173.99%24.9M
898.99%16.77M
152.21%6.73M
154.75%4.48M
78.31%-3.09M
23.55%-33.65M
117.06%1.68M
-162.43%-12.89M
48.76%-8.19M
Net non-operating interest income expense
7.31%-5.68M
3.27%-24.34M
16.21%-5.69M
7.27%-6.11M
3.94%-6.41M
-19.98%-6.13M
-15.12%-25.16M
-14.92%-6.79M
-15.07%-6.59M
-25.79%-6.67M
Non-operating interest income
2.30%1.2M
-10.88%4.74M
60.55%1.46M
-3.26%1.16M
-26.57%948K
-38.90%1.18M
12.00%5.32M
-17.80%910K
6.78%1.2M
5.56%1.29M
Non-operating interest expense
-5.76%6.88M
-4.60%29.08M
-7.14%7.15M
-6.65%7.27M
-7.61%7.36M
3.88%7.31M
14.57%30.49M
9.76%7.7M
13.71%7.79M
22.00%7.96M
Total other finance cost
----
----
----
----
----
----
--2.69M
--0
----
----
Other net income (expense)
-27.83%1.71M
-99.95%1K
122.25%420K
-21.25%604K
Gain on sale of security
----
----
----
----
----
----
700.00%8K
150.00%1K
----
121.43%3K
Special income (charges)
----
--0
--0
--0
--0
--0
-28.14%1.7M
--0
122.05%420K
-23.05%601K
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
--0
15.62%-4.39M
--0
54.94%-420K
23.05%-601K
-Less:Other special charges
----
----
----
----
----
----
-5.18%2.69M
--0
----
----
Income before tax
124.23%2.23M
100.97%554K
316.72%11.08M
103.26%621K
86.48%-1.93M
50.62%-9.22M
10.08%-57.1M
62.48%-5.11M
-52.17%-19.06M
30.52%-14.26M
Income tax
0
0
0
0
0
0
-81.59%-2.27M
0
-883.43%-3.32M
210.96%749K
Net income
124.23%2.23M
101.01%554K
316.72%11.08M
103.95%621K
87.15%-1.93M
51.42%-9.22M
11.92%-54.84M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
Net income continuous Operations
124.23%2.23M
101.01%554K
316.72%11.08M
103.95%621K
87.15%-1.93M
51.42%-9.22M
11.92%-54.84M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
Minority interest income
Net income attributable to the parent company
124.23%2.23M
101.01%554K
316.72%11.08M
103.95%621K
87.15%-1.93M
51.42%-9.22M
11.92%-54.84M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
124.23%2.23M
101.01%554K
316.72%11.08M
103.95%621K
87.15%-1.93M
51.42%-9.22M
11.92%-54.84M
61.81%-5.11M
-29.12%-15.74M
24.38%-15.01M
Basic earnings per share
116.67%0.01
0
333.33%0.07
0
90.00%-0.01
57.14%-0.06
17.78%-0.37
66.67%-0.03
-22.22%-0.11
28.57%-0.1
Diluted earnings per share
116.67%0.01
0
300.00%0.06
0
90.00%-0.01
57.14%-0.06
17.78%-0.37
66.67%-0.03
-22.22%-0.11
28.57%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 38.27%83.13M43.72%291.85M42.78%85.81M37.06%74.38M48.84%71.54M47.94%60.12M23.89%203.07M35.39%60.1M12.31%54.27M26.46%48.07M
Operating revenue 38.27%83.13M43.72%291.85M42.78%85.81M37.06%74.38M48.84%71.54M47.94%60.12M23.89%203.07M35.39%60.1M12.31%54.27M26.46%48.07M
Cost of revenue 21.15%10.57M15.58%42.57M15.50%10.95M-19.11%11M52.73%11.9M46.17%8.73M28.58%36.83M25.20%9.48M65.75%13.59M3.11%7.79M
Gross profit 41.18%72.55M49.95%249.28M47.88%74.86M55.83%63.38M48.08%59.64M48.24%51.39M22.89%166.24M37.48%50.62M1.39%40.68M32.25%40.28M
Operating expense 18.64%64.64M12.26%224.38M18.69%58.09M5.76%56.65M13.82%55.16M11.39%54.48M11.49%199.88M4.89%48.94M18.96%53.57M4.37%48.46M
Selling and administrative expenses 20.73%53.14M11.56%182.37M18.34%47.5M3.31%46.46M11.00%44.39M14.69%44.02M11.90%163.48M6.84%40.14M20.60%44.97M6.27%39.99M
Research and development costs 13.29%8.78M21.93%31.17M29.25%7.87M27.09%7.48M39.87%8.06M-0.87%7.75M14.41%25.56M-4.54%6.09M16.96%5.89M-5.39%5.76M
Depreciation amortization depletion 0.00%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.04%2.71M-0.04%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M
-Depreciation and amortization 0.00%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.04%2.71M-0.04%2.71M0.00%10.84M0.00%2.71M0.00%2.71M0.00%2.71M
Operating profit 356.18%7.92M173.99%24.9M898.99%16.77M152.21%6.73M154.75%4.48M78.31%-3.09M23.55%-33.65M117.06%1.68M-162.43%-12.89M48.76%-8.19M
Net non-operating interest income expense 7.31%-5.68M3.27%-24.34M16.21%-5.69M7.27%-6.11M3.94%-6.41M-19.98%-6.13M-15.12%-25.16M-14.92%-6.79M-15.07%-6.59M-25.79%-6.67M
Non-operating interest income 2.30%1.2M-10.88%4.74M60.55%1.46M-3.26%1.16M-26.57%948K-38.90%1.18M12.00%5.32M-17.80%910K6.78%1.2M5.56%1.29M
Non-operating interest expense -5.76%6.88M-4.60%29.08M-7.14%7.15M-6.65%7.27M-7.61%7.36M3.88%7.31M14.57%30.49M9.76%7.7M13.71%7.79M22.00%7.96M
Total other finance cost --------------------------2.69M--0--------
Other net income (expense) -27.83%1.71M-99.95%1K122.25%420K-21.25%604K
Gain on sale of security ------------------------700.00%8K150.00%1K----121.43%3K
Special income (charges) ------0--0--0--0--0-28.14%1.7M--0122.05%420K-23.05%601K
-Less：Restructuring and merger&acquisition ------0--0--0--0--015.62%-4.39M--054.94%-420K23.05%-601K
-Less:Other special charges -------------------------5.18%2.69M--0--------
Income before tax 124.23%2.23M100.97%554K316.72%11.08M103.26%621K86.48%-1.93M50.62%-9.22M10.08%-57.1M62.48%-5.11M-52.17%-19.06M30.52%-14.26M
Income tax 000000-81.59%-2.27M0-883.43%-3.32M210.96%749K
Net income 124.23%2.23M101.01%554K316.72%11.08M103.95%621K87.15%-1.93M51.42%-9.22M11.92%-54.84M61.81%-5.11M-29.12%-15.74M24.38%-15.01M
Net income continuous Operations 124.23%2.23M101.01%554K316.72%11.08M103.95%621K87.15%-1.93M51.42%-9.22M11.92%-54.84M61.81%-5.11M-29.12%-15.74M24.38%-15.01M
Minority interest income
Net income attributable to the parent company 124.23%2.23M101.01%554K316.72%11.08M103.95%621K87.15%-1.93M51.42%-9.22M11.92%-54.84M61.81%-5.11M-29.12%-15.74M24.38%-15.01M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 124.23%2.23M101.01%554K316.72%11.08M103.95%621K87.15%-1.93M51.42%-9.22M11.92%-54.84M61.81%-5.11M-29.12%-15.74M24.38%-15.01M
Basic earnings per share 116.67%0.010333.33%0.07090.00%-0.0157.14%-0.0617.78%-0.3766.67%-0.03-22.22%-0.1128.57%-0.1
Diluted earnings per share 116.67%0.010300.00%0.06090.00%-0.0157.14%-0.0617.78%-0.3766.67%-0.03-22.22%-0.1128.57%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.39%
Sample Name
Sample Code
 +5.17%
Sample Name
Sample Code
 +2.86%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+2.61%
5
VanEck Oil Services ETF
OIH
+2.39%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.74%
Sample Name
Sample Code
 +0.72%
Sample Name
Sample Code
 +0.56%
4
H World Group
HTHT
-0.71%
5
Yum China
YUMC
-0.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Iran's Fars News Agency, the Iranian armed forces announced the conclusion of their military operations against Israel but warn Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -